Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Atlas, CMEA Test New Biotech Model

01 Apr 2011

• By Alex Lash

Related Content

Lilly's Evolving Corporate Venture Model

01 Oct 2010

With Pharma Ready to Pare Portfolios, Project Financing Funds Make Their Pitches

01 Jun 2010

Unnamed Lilly "Mirror Fund" Acquires First Two Compounds

15 Feb 2011

Two's a Crowd: Versartis Raises $21 Million Series B, Cleaves Off Diabetes Asset to Form Diartis Pharma

16 Feb 2011

Back To The Drawing Board For Portola After Merck Returns Betrixaban

24 Mar 2011

PanGenetics' NGF Antibody Sale Illustrates Index's Asset-Focused Strategy

01 Dec 2009

Corporate VC Adds a Business Development Flavor

01 Nov 2007

Related Companies

Portola Pharmaceuticals, Inc.

Eli Lilly and Company

Abbott

Additional Topics

Strategy Business Strategies

More from Strategy

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.